New liver support protocol could help patients avoid transplant

NCT ID NCT07593638

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a treatment for adults with acute-on-chronic liver failure, a sudden worsening of long-term liver disease. The approach combines blood filtering (hemoadsorption) with half-dose plasma exchange to support the liver until recovery or transplant. About 240 participants will receive either this protocol or standard care, and researchers will track survival and need for liver transplant at 28 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ON CHRONIC LIVER FAILURE (ACLF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Acute-On-Chronic Liver Failure liver failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Unidade Hospitalar de Bragança

    Bragança, Braganza District, 5301-852, Portugal

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact